Pure Pharma Limited, a active public limited company, was established on 21 August 1980 in Indore, Madhya Pradesh, India. Engaging in food & beverage retail & distribution within the trade sector, it holds CIN: U24232MP1980PLC001647. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹2.50 Cr.
It upholds a compliant status. Employing 7 professional, Its leadership includes Subhash Rijhwani (Director), Mahesh Badlani (Director), Pankaj Badlani (Director). Past directors included Robin Jain, Usha Badlani, Subhash Rijhwani. It holds no open charges and ₹27.13 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G-3, Shreenath Niketan, 29, Snehalataganj Near Bhandari Bridge, Indore, Madhya Pradesh, 452006.
U24232MP1980PLC001647
001647
21 August 1980
₹4.50 Cr
₹2.50 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Pure Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subhash Rijhwani | Director | 12 Feb 2021 | Current |
| Mahesh Badlani | Director | 01 Apr 2001 | Current |
| Pankaj Badlani | Director | 16 May 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Sep 2011 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 12 Feb 2021 | Past |
| Pramod Abcsdd | Director | 26 Sep 2018 | Past |
| Pramod Abcsdd | Director | 31 Jan 2011 | Past |
| Pramod Abcsdd | Director | 16 May 2019 | Past |
| Pramod Abcsdd | Director | 26 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pure Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 23.71% decrease. The company also saw a substantial fall in profitability, with a 45.65% decrease in profit. The company's net worth dipped by a decrease of 4.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Pure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹271,250,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2011 | Madhya Pradesh Financial Corporation | ₹1.50 Cr | Satisfied |
| 23 Mar 2010 | Madhya Pradesh Financial Corporation | ₹1.50 Cr | Satisfied |
| 14 Oct 2009 | State Bank Of India | ₹7.50 M | Satisfied |
| 01 Oct 2008 | Madhya Pradesh Financial Coporation | ₹1.50 Cr | Satisfied |
| 22 Mar 2007 | Madhya Pradesh Financial Corporation | ₹2.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Pure Pharma has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Pure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pure Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pure Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Pure Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
The activity Subhash Rijhwani was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 9 months . was completed.
The activity Pankaj Badlani was appointed as a Director was appointed as a Director on 16 May 2019 & has been associated with this company since 6 years 6 months . was completed.
Progress on A charge registered on 22 Mar 2007 via Charge ID 10043831 with Madhya Pradesh Financial Corporation was fully satisfied on 08 May 2017. was documented.
The activity A charge registered on 21 Feb 2002 via Charge ID 90209008 with Madhya Pradesh Financial Corporation was fully satisfied on 08 May 2017. was completed.
The CIN of Pure Pharma Limited is U24232MP1980PLC001647.
Pure Pharma Limited is headquartered at G-3, Shreenath Niketan, 29, Snehalataganj Near Bhandari Bridge, Indore, Madhya Pradesh, 452006.
Pure Pharma Limited was incorporated on 21 August 1980.
The current directors of Pure Pharma Limited are
The primary industry of Pure Pharma Limited is Trade.
Pure Pharma Limited is unlisted.
The authorized capital of Pure Pharma Limited is ₹4.50 Cr, and the paid-up capital is ₹2.50 Cr.
The compliance status of Pure Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX